Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Anal Cancer AJCC v8”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Large-scale testing (Phase 3)Study completedNCT00025090
What this trial is testing

Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer

Who this might be right for
Anal Cancer
University College London (UCL) Cancer Institute 600
Testing effectiveness (Phase 2)Study completedNCT03690921
What this trial is testing

Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial

Who this might be right for
Anal Canal Squamous Cell CarcinomaStage I Anal Cancer AJCC v8Stage II Anal Cancer AJCC v8+6 more
M.D. Anderson Cancer Center 8
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Large-scale testing (Phase 3)Study completedNCT00075868
What this trial is testing

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Who this might be right for
Anal CancerColorectal CancerDrug/Agent Toxicity by Tissue/Organ+1 more
Radiation Therapy Oncology Group 233
Not applicableStudy completedNCT05130073
What this trial is testing

4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer

Who this might be right for
Anal Squamous Cell CarcinomaStage 0 Anal Cancer AJCC v8Stage I Anal Cancer AJCC v8+7 more
M.D. Anderson Cancer Center 41
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableEnded earlyNCT02140021
What this trial is testing

Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenocarcinoma In SituCervical Intraepithelial Neoplasia+52 more
M.D. Anderson Cancer Center 409
Not applicableStudy completedNCT00059891
What this trial is testing

Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer

Who this might be right for
Anal CancerColorectal CancerPerioperative/Postoperative Complications
Memorial Sloan Kettering Cancer Center 4
Not applicableLooking for participantsNCT07112690
What this trial is testing

Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer Treatment

Who this might be right for
Localized Anal CarcinomaLocalized Anal Margin CarcinomaStage 0 Anal Cancer AJCC v8+3 more
Emory University 5
Testing effectiveness (Phase 2)Study completedNCT00324415
What this trial is testing

Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer

Who this might be right for
Anal Cancer
AIDS Malignancy Consortium 45
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04166318
What this trial is testing

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Canal Squamous Cell Carcinoma+3 more
ECOG-ACRIN Cancer Research Group 252
Testing effectiveness (Phase 2)Study completedNCT00316888
What this trial is testing

Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer

Who this might be right for
Anal Cancer
ECOG-ACRIN Cancer Research Group 63